Reuters logo
BRIEF-Glaxosmithkline says ‍Hal Barron appointed as chief scientific officer and president, research and development​
November 8, 2017 / 2:10 PM / a month ago

BRIEF-Glaxosmithkline says ‍Hal Barron appointed as chief scientific officer and president, research and development​

Nov 8 (Reuters) - Glaxosmithkline Plc

* ‍HAL BARRON HAS BEEN APPOINTED CHIEF SCIENTIFIC OFFICER AND PRESIDENT, RESEARCH AND DEVELOPMENT​

* ‍BARRON IS CURRENTLY PRESIDENT RESEARCH AND DEVELOPMENT AT CALICO​

* ‍BARRON WILL ASSUME HIS NEW ROLE AND JOIN BOARD ON 1 JANUARY 2018​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below